WHO-ICMRA joint statement on the need for improved global regulatory alignment on COVID-19 medicines and vaccines
The International Coalition of Medicines Regulatory Authorities (ICMRA) and the World Health Organization (WHO) have committ…
The International Coalition of Medicines Regulatory Authorities (ICMRA) and the World Health Organization (WHO) have committ…
Although medicines used for neglected tropical diseases (NTDs) continue to effective, antimicrobial resistance can compromis…
UNICEF and the World Health Organization (WHO) today issued an urgent call to action to avert major measles and polio epide…
As health leaders prepare to gather for a virtual session of the resumed 73 rd World Health Assembly (WHA), WHO has three …
On 4 November 2020, WHO published a series of Health and Climate Change Country Profiles for Small Island Developing States.…
The Global Programme to Eliminate Lymphatic Filariasis (GPELF) has delivered over 8.2 billion cumulative treatments to more …
For medicines to work safely, it’s vital to have strong systems in place to report any undesired side effects or “adverse dr…
Scaling up efforts on the prevention and control of non-communicable diseases (NCDs) can avert over 4.3 million deaths and y…
WHO and partners launch new guidance on designing digital health interventions with and for young people. Digital tool…
Special series aims to advance women’s health and gender equality. Progress on gender equality has been made in all 12 key …